Many chemotherapeutic agents introduced for use in humans are carcinogenic in laboratory animals (Conklin et al. Combinations of drugs, administered as the primary treatment, have resulted in high rates of cure in patients with disseminated malignancies, such as stage IV Hodgkin's disease or childhood acute lymphocytic leukemia.